Intersect Capital’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
Other funds holding INVA
SCM
PI
Intersect Capital's INVA Position: Q2 2022 in Review
Intersect Capital increased its Innoviva (INVA) stake by 3.6% in Q2 2022, buying an estimated $17.4K and bringing the position to 30,432 shares worth $449K. The position accounts for 0.14% of the portfolio, ranked #164.
Intersect Capital first reported a position in INVA in Q3 2021 and has held it in 4 quarters since. The position peaked at $568K in Q1 2022. 218 funds tracked by Wall St. Rank hold INVA as of Q2 2022.
- Intersect Capital held 30,432 shares of Innoviva worth $449K as of Q2 2022.
- Intersect Capital bought 1,064 Innoviva shares in Q2 2022, an estimated $17.4K.
- Innoviva made up 0.14% of Intersect Capital's portfolio in Q2 2022, its #164 holding.
- Intersect Capital first reported a position in Innoviva in Q3 2021 and has held it in 4 quarters since.
- Intersect Capital's Innoviva position peaked at $568K in Q1 2022.
- 218 funds tracked by Wall St. Rank held Innoviva as of Q2 2022.
Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.